Carregant...
In Reply
Our meta-analysis provides evidence that zoledronic acid in the adjuvant breast cancer setting may increase survival. Additional data from basic research and clinical trials in the future will help us interpret its role with more confidence.
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755942/ https://ncbi.nlm.nih.gov/pubmed/23986347 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0235 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|